Stay updated on Adjunctive Troriluzule in OCD Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.

Latest updates to the Adjunctive Troriluzule in OCD Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check10 days agoChange DetectedA notice appears explaining that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.SummaryDifference0.3%

- Check17 days agoChange DetectedThe ClinicalTrials.gov site revision updated from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check24 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check45 days agoChange DetectedA new Revision: v3.7.0 was added to the study record history, and the previous Revision: v3.6.6 entry was removed, reflecting an update to the page's revision history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page history adds a new Revision: v3.6.6 entry and removes the previous Revision: v3.6.5, reflecting an update to the page's version history.SummaryDifference0.0%

Stay in the know with updates to Adjunctive Troriluzule in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Troriluzule in OCD Clinical Trial page.